These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23332885)

  • 1. [Idaptan(®) (trimetazidine): the panacea].
    Sempere Manuel M; Roth Damas P; Gonzálvez Perales JL; Palop Larrea V
    Aten Primaria; 2013 Apr; 45(4):226-7. PubMed ID: 23332885
    [No Abstract]   [Full Text] [Related]  

  • 2. [Response to Idaptan(®) (trimetazidine): the panacea].
    Aguirre C; García García M; Etxebarria Aretxaga A
    Aten Primaria; 2014 Jan; 46(1):51-2. PubMed ID: 24183656
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trimetazidine (Preductal). A new approach in controlling myocardial ischemia].
    Eliseev OM
    Ter Arkh; 1996; 68(8):57-63. PubMed ID: 9019836
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trimetazidine-a new aetiology for extrapyramidal disorders: A case of parkinsonism and akathisia].
    Masmoudi K; Gras-Champel V; Douadi Y; Masson H; Andréjak M
    Therapie; 2005; 60(6):603-5. PubMed ID: 16555505
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy and tolerability of trimetazidine in the treatment of stable effort angina (TRIUMPH Study in Russia)].
    Makolkin VI; Osadchiĭ KK;
    Kardiologiia; 2003; 43(6):18-22. PubMed ID: 12974255
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible Parkinsonism linked to trimetazidine (continued).
    Prescrire Int; 2006 Aug; 15(84):136. PubMed ID: 16989026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible Parkinsonism linked to trimetazidine.
    Prescrire Int; 2005 Apr; 14(76):63. PubMed ID: 15875344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimetazidine: a second look. Still no efficacy in visual disorders.
    Prescrire Int; 2002 Aug; 11(60):101-5. PubMed ID: 12199261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimetazidine: a second look. Just a placebo.
    Prescrire Int; 2000 Feb; 9(45):207-9. PubMed ID: 11503798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ; Plosker GL
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimetazidine for stable angina.
    Ciapponi A; Pizarro R; Harrison J
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003614. PubMed ID: 16235330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
    Ferrari R; Ford I; Fox K; Challeton JP; Correges A; Tendera M; Widimský P; Danchin N;
    Lancet; 2020 Sep; 396(10254):830-838. PubMed ID: 32877651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of trimetazidine on myocardial perfusion and the contractile response of chronically dysfunctional myocardium in ischemic cardiomyopathy: a 24-month study.
    El-Kady T; El-Sabban K; Gabaly M; Sabry A; Abdel-Hady S
    Am J Cardiovasc Drugs; 2005; 5(4):271-8. PubMed ID: 15984909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics.
    Ferrari R; Ford I; Fox K; Marzilli M; Tendera M; Widimský P; Challeton JP; Danchin N
    Am Heart J; 2019 Apr; 210():98-107. PubMed ID: 30771737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
    Sellier P; Broustet JP
    Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Trimetazidine and Parkinsonism: A Population-Based Study.
    Kwon J; Yu YM; Kim S; Jeong KH; Lee E
    Neuroepidemiology; 2019; 52(3-4):220-226. PubMed ID: 30831572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimetazidine: new French pharmacovigilance data.
    Prescrire Int; 2010 Apr; 19(106):74. PubMed ID: 20568493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel drugs for treating angina.
    Jones DA; Timmis A; Wragg A
    BMJ; 2013 Sep; 347():f4726. PubMed ID: 24018101
    [No Abstract]   [Full Text] [Related]  

  • 19. The antiischemic effects and tolerability of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL-1.
    Szwed H; Sadowski Z; Pachocki R; Domzał-Bocheńska M; Szymczak K; Szydłowski Z; Paradowski A; Gajos G; Kałuza G; Kulon I; Wator-Brzezińska A; Elikowski W; Kuźniak M
    Cardiovasc Drugs Ther; 1999 May; 13(3):217-22. PubMed ID: 10439884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent.
    McCarthy CP; Mullins KV; Kerins DM
    Eur Heart J Cardiovasc Pharmacother; 2016 Oct; 2(4):266-72. PubMed ID: 27533944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.